Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Johann Bauersachs Added: 9 months ago
ESC HF 25 - SCD-PROTECT shows high risk of sudden cardiac arrest (SCA) and sudden cardiac death (SCD) during early medical therapy optimization for reduced LVEF in patients with new non-ischemic cardiomyopathy or MI/CAD.Prof Johann Bauersachs (Hannover Medical School, Hannover, DE) discusses findings from the SCD–PROTECT study, an investigation of sudden cardiac arrest in patients with newly… View more
Author(s): Johann Bauersachs Added: 9 months ago
ESC HF 25 - SCD-PROTECT zeigt hohes Risiko für plötzlichen Herzstillstand (SCA) und plötzlichen Herztod (SCD) während der frühen medikamentösen Therapieoptimierung bei reduzierter LVEF bei Patienten mit neu diagnostizierter nicht-ischämischer Kardiomyopathie oder MI/KHK.Prof Johann Bauersachs (Medizinische Hochschule Hannover, Hannover, DE) diskutiert Ergebnisse aus dem SCD-PROTECT studie, einer… View more
Author(s): Muthiah Vaduganathan Added: 1 year ago
HFA 24 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the findings from a study of four large-scale placebo controlled-trials investigating the timing of cardio-kidney protection with SGLT2 inhibitors.4 trials that sampled distinct patient populations were enrolled in the trial - the CANVAS program, the CREDENCE trial, DAPA-HF and DELIVER. Across each… View more
Author(s): James Burton Added: 1 year ago
Chaired by Prof James Burton (University of Leicester, UK), this roundtable features expert insight from a world-renowned faculty, Prof David Wheeler (University College London, UK) and Dr Navdeep Tangri (University of Manitoba, CA).Dr Tangri begins by providing an overview of the recent KDIGO guideline updates. Following this, the panel recap on the patient case that was presented in part one of… View more
Author(s): Navdeep Tangri , James Burton , David Wheeler Added: 1 year ago
Part one of this two-part programme focuses on our current guideline-directed approach to chronic kidney disease (CKD) and how SGLT-2 inhibitors can be used to maximal effect. Chaired by Prof James Burton (University of Leicester, UK), this roundtable features expert insight from a world-renowned faculty, Prof David Wheeler (University College London, UK), Dr Navdeep Tangri (University of… View more
Dr Daniel Gaudet founded the Université de Montréal Community Genomics Medicine Center, the Lipid Research Group and the Lipid Clinic at the Chicoutimi Hospital, where he was also director of research from 2003 to 2012.In 2000, Dr. Gaudet founded ECOGENE-21, a non-profit organisation in translational medicine and systems approach whose aim is the acquisition of new knowledge, the development and… View more
Job title: Consultant and Professor of Cardiology
Personal History Professor Ross Jacob Hunter was born in 1977 in the UK. He is a Consultant Cardiologist specialising in arrhythmia management and the clinical lead for AF services at The Barts Heart Centre.3 Academic History Prof Hunter earned his BSc in Cardiovascular Medicine from Imperial College London in 1998. In 2001, he was awarded an MBBS with a distinction from Guy’s Kings … View more
Job title: Consultant Interventional Cardiologist
Dr Clint Anthony Maart graduated with MBChB (First Class Honours) from the University of Cape Town and Groote Schuur medical school in 2002. He attained membership of the Royal College of Physicians (MRCP) during specialist doctor training at Cambridge University Hospitals Trust. Dr Maart then commenced clinical cardiology training in Cardiology on the East of England national training number … View more